DE60236136D1 - Zusammensetzungen zur Steigerung des überlebens von Wassertieren, die einem RNS-Virus ausgesetzt sind - Google Patents

Zusammensetzungen zur Steigerung des überlebens von Wassertieren, die einem RNS-Virus ausgesetzt sind

Info

Publication number
DE60236136D1
DE60236136D1 DE60236136T DE60236136T DE60236136D1 DE 60236136 D1 DE60236136 D1 DE 60236136D1 DE 60236136 T DE60236136 T DE 60236136T DE 60236136 T DE60236136 T DE 60236136T DE 60236136 D1 DE60236136 D1 DE 60236136D1
Authority
DE
Germany
Prior art keywords
infection
survival
bimavirus
aquatic
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60236136T
Other languages
English (en)
Inventor
Ana Maria Sandino
Geraldine Mlynarz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42140308&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60236136(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60236136D1 publication Critical patent/DE60236136D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60236136T 2001-12-07 2002-12-09 Zusammensetzungen zur Steigerung des überlebens von Wassertieren, die einem RNS-Virus ausgesetzt sind Expired - Lifetime DE60236136D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33668401P 2001-12-07 2001-12-07

Publications (1)

Publication Number Publication Date
DE60236136D1 true DE60236136D1 (de) 2010-06-10

Family

ID=42140308

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60236136T Expired - Lifetime DE60236136D1 (de) 2001-12-07 2002-12-09 Zusammensetzungen zur Steigerung des überlebens von Wassertieren, die einem RNS-Virus ausgesetzt sind

Country Status (9)

Country Link
US (2) US7652050B2 (de)
EP (2) EP2193792B1 (de)
AT (2) ATE465730T1 (de)
CA (1) CA2428703A1 (de)
CL (1) CL2008003293A1 (de)
DE (1) DE60236136D1 (de)
DK (2) DK2193792T3 (de)
ES (2) ES2372915T3 (de)
NO (2) NO20025898L (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2620440C (en) * 2005-08-29 2014-01-28 Novartis Ag Use of oxazole derivatives for controlling fish parasites
NO20055541L (no) * 2005-11-23 2007-05-24 Berge Biomed As Use of fatty acid analogues
EP2586446B1 (de) * 2010-06-08 2015-12-16 Laboratorio De Diagnostico Gam, S.a. Verwendung von 1-beta-d-ribofuranosyl-1h-1,2,4-triazol-3-carboxamid zur behandlung von infektiöser anämie der salmoniden (isa)
WO2013059168A2 (en) * 2011-10-21 2013-04-25 Research Development Foundation Espirito santo virus and methods for detecting and preventing infection with the same
KR101540696B1 (ko) 2014-12-12 2015-08-03 대한민국 바이러스 내성 넙치 육종 방법
MX2024007822A (es) * 2021-12-22 2024-07-04 Cj Cheiljedang Corp Composicion antiviral que comprende analogos nucleosidicos derivados de acido nucleico y sal farmaceuticamente aceptable de los mismos.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878047A (en) 1973-02-02 1975-04-15 Upjohn Co Process for production of AT-125
US4256898A (en) 1978-05-15 1981-03-17 The Upjohn Company α(substituted) Amino-3-substituted-2-isoxazoline-5-acetic acids (esters)
USRE31578E (en) 1978-05-15 1984-05-01 The Upjohn Company α(Substituted) amino-3-substituted-2-isoxazoline-5-acetic acids (esters)
US4225720A (en) 1978-05-15 1980-09-30 The Upjohn Company Purification of AT-125
US4232164A (en) 1978-05-15 1980-11-04 The Upjohn Company Purification of AT-125
JPS5793968A (en) * 1980-11-11 1982-06-11 Sankyo Co Ltd Carbamic acid ester and insecticide containing the same
US4843087A (en) * 1983-08-29 1989-06-27 Sterling Drug Inc. Di-heterocyclic compounds and their use as antiviral agents
US5087639A (en) * 1988-11-02 1992-02-11 The Upjohn Company Preventing CNS toxicity of acivicin when used with four large neutral amino acids
KR920703082A (ko) 1989-12-27 1992-12-17 후지사와 도모끼찌로 어류 질병의 예방 및 치료제
US5349068A (en) 1992-04-15 1994-09-20 Sterling Winthrop Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US20020058911A1 (en) * 1999-05-07 2002-05-16 Paul Gilson Support frame for an embolic protection device
US6540722B1 (en) * 1999-12-30 2003-04-01 Advanced Cardiovascular Systems, Inc. Embolic protection devices
US6689151B2 (en) * 2001-01-25 2004-02-10 Scimed Life Systems, Inc. Variable wall thickness for delivery sheath housing
WO2003055413A2 (en) * 2001-12-21 2003-07-10 Salviac Limited A support frame for an embolic protection device
US8182508B2 (en) * 2005-10-04 2012-05-22 Cook Medical Technologies Llc Embolic protection device
US20070239198A1 (en) * 2006-04-03 2007-10-11 Boston Scientific Scimed, Inc. Filter and wire with distal isolation

Also Published As

Publication number Publication date
CL2008003293A1 (es) 2009-03-20
EP2193792B1 (de) 2011-08-31
NO20110661L (no) 2003-06-10
EP2193792A1 (de) 2010-06-09
NO335129B1 (no) 2014-09-22
NO20025898L (no) 2003-06-10
US20100204290A1 (en) 2010-08-12
NO20025898D0 (no) 2002-12-09
DK2193792T3 (da) 2012-01-02
CA2428703A1 (en) 2004-11-14
US8044031B2 (en) 2011-10-25
ATE522212T1 (de) 2011-09-15
ES2372915T3 (es) 2012-01-27
ES2345244T3 (es) 2010-09-20
EP1317923B1 (de) 2010-04-28
US20030191169A1 (en) 2003-10-09
EP1317923A2 (de) 2003-06-11
ATE465730T1 (de) 2010-05-15
US7652050B2 (en) 2010-01-26
DK1317923T3 (da) 2010-08-09
EP1317923A3 (de) 2003-09-10

Similar Documents

Publication Publication Date Title
EA200800209A1 (ru) N-тиоантраниламидные соединения и их применение в качестве пестицидов
DE602004014791D1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
EA200500723A1 (ru) Соединения бензофурана, композиции и способы лечения и профилактики инфекций, вызванных вирусом гепатита c, и связанных с ним заболеваний
DE69935721D1 (de) Kälte-adaptierte pferde influenza-viren
DE602004019198D1 (de) Chinolin-2-on-derivate zur behandlung von erkankungen der atemwege
EA200601095A1 (ru) Замещённые гетероароилом фенилаланинамиды
RU2016129272A (ru) Применение изоксазолиновых соединений на домашней птице
CL2008003293A1 (es) Uso de neomicina para preparar un medicamento para tratar y prevenir una infección causada por un virus birnaviridae en un animal acuatico (div. sol. n°2800-02)
BRPI0507801A (pt) compostos de azetidina substituìda, processo para a preparação de compostos de azetidina substituìda, medicamento e uso de pelo menos um composto de azetidina substituìda
WO2001060849A3 (en) Cold-adapted equine influenza viruses
ATE72980T1 (de) Anthelmintische quaternaere alkyl-acyl-hydrazone, verfahren zur verwendung und zusammensetzungen.
US7140323B2 (en) Reducing the level of bacteria and viruses in aquaculture
ATE77237T1 (de) Anthelmintische acylhydrazone, verfahren zur verwendung und zusammensetzungen.
ATE71839T1 (de) Anthelmintische acylhydrazone verfahren zur verwendung und zusammensetzungen.
Roy et al. Ontogenetic profile of Antiviral Mx gene and its role in innate immunity in Mrigal, Cirrhinus mrigala (Hamilton 1822)
DE50208413D1 (de) Verfahren zur herstellung von d-pantothensäure und/oder deren salze als zusatz zu tierfuttermitteln
EA200702350A1 (ru) Анилиды тиазолкарбоновой кислоты
BRPI0416389A (pt) processo para remover substáncias queratinosas de peles de animais mortos, couro, composto, e, processo para preparar o mesmo
CA2997521A1 (en) Feed composition for prevention and treatment of parasite infection of fish
TH92454A (de)
RU2002133057A (ru) Способ оральной иммунизации птицы против ньюкаслской болезни
DE60310975D1 (de) Verwendung von epothilone zur behandlung hyperparathyreoidismus
EA200000231A1 (ru) Корм для животных и птиц и способ его приготовления
Voronova et al. History and Condition Artificial Reproduction of Aquatic Biological Resources in the Fisheries Basin of Baikal
NO20014372D0 (no) Isolering og delvis karakterisering av en ny antiprokferativ komponent fra humane leukocytter

Legal Events

Date Code Title Description
8364 No opposition during term of opposition